首页> 外文OA文献 >PP-110 Chinese herbal medicines (CHM) personalized therapy for HBeAg(+) chronic hepatitis B Chinese patient with suboptimal response to nucleoside and modeling

【2h】

PP-110 Chinese herbal medicines (CHM) personalized therapy for HBeAg(+) chronic hepatitis B Chinese patient with suboptimal response to nucleoside and modeling

机译：PP-110中药（CHM）个性化治疗HBeAg（+）慢性乙型肝炎患者对核苷和模型的反应欠佳

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ye Y.G.; Min L.Q.;
展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. PP-110 Chinese herbal medicines (CHM) personalized therapy for HBeAg(+) chronic hepatitis B Chinese patient with suboptimal response to nucleoside and modeling [J] . Y.G.Ye, L.Q.Min International journal of infectious diseases : . 2011,第Supplementa1期

机译：PP-110中药（CHM）个性化治疗HBeAg（+）慢性乙型肝炎患者对核苷和模型的反应欠佳
2. Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multicener, double-blind, randomized controlled trial in China [J] . Xiaoke Li, Ludan Zhang, Mei Qiu, Trials . 2020,第1期

机译：中草药联合Entecavir，减少HBeAg阳性慢性乙型肝炎患者的脱疗复发风险：中国的多级，双盲，随机对照试验
3. Modeling and Simulating Dynamics of Complete- and Poor-Response Chronic Hepatitis B Chinese Patients for Adefovir and Traditional Chinese Medicine Plus Adefovir Therapy [J] . Lequan Min, Xiao Chen, Yongan Ye, Evidence-based complementary and alternative medicine: eCAM . 2013,第18期

机译：中国人对Adefovir和中药加Adefovir治疗的完全应答和不良反应的慢性乙型肝炎患者的建模和模拟动力学
4. Chinese herbal medicine Xiaoyao san (XYS) for chronic hepatitis B (CHB): A meta-analysis of randomized controlled trials [C] . Su Ke-lei, An Zhen-tao, Zhu Fang-shi 2014 IEEE Workshop on Electronics, Computer and Applications . 2014

机译：中药逍遥散（XYS）治疗慢性乙型肝炎（CHB）：一项随机对照试验的荟萃分析
5. 信息不对称下，“中药材全产业链服务商”模式对中药材价格的影响研究 =Pricing and Information Asymmetry in the Chinese Herbal Medicine Markets - A Study of the Mode of "Chinese Herbal Medicine Industry Chain Service Provider" [D] . Yin, Xiaowei. 2019

机译：信息不对称下，“中药材全产业链服务商”模式对中药材价格的影响研究 =Pricing and Information Asymmetry in the Chinese Herbal Medicine Markets - A Study of the Mode of "Chinese Herbal Medicine Industry Chain Service Provider"
6. Modeling and Simulating Dynamics of Complete- and Poor-Response Chronic Hepatitis B Chinese Patients for Adefovir and Traditional Chinese Medicine Plus Adefovir Therapy [O] . Lequan Min, Xiao Chen, Yongan Ye, 2013

机译：中国人对Adefovir和中药加Adefovir治疗的完全应答和不良反应的慢性乙型肝炎患者的建模和模拟动力学
7. Chinese herbal medicine combined with entecavir to reduce the off-therapy recurrence risk in HBeAg-positive chronic hepatitis B patients: a multi-center, double-blind, randomized controlled trial in China [O] . Xiaoke Li, Ludan Zhang, Mei Qiu, 2020

机译：中草药联合Entecavir，减少HBeAg阳性慢性乙型肝炎患者的脱疗复发风险：中国的多中心，双盲，随机对照试验

PP-110 Chinese herbal medicines (CHM) personalized therapy for HBeAg(+) chronic hepatitis B Chinese patient with suboptimal response to nucleoside and modeling

著录项

引文网络

相似文献

相关主题

期刊订阅